Cocrystal Pharma
Price & Volume
Stats
See more52W Range | $0.85-$2.19 |
Market Cap | $14.1M |
Shares Short | 214,196 |
Financials
See moreRevenue (12 Mos) | $510,000 |
Revenue Growth (YoY) | 26.9% |
Gross Profit (12 Mos) | -$5.4M |
Diluted EPS | -$0.93 |
News
See moreYahoo Finance • last month
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Yahoo Finance • 4 months ago
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Yahoo Finance • 6 months ago
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Yahoo Finance • 6 months ago
BC-Most Active Stocks
About
CEO | Dr. Sam Lee Ph.D. |
CFO | Mr. James J. Martin CPA, M.B.A. |
Address | 19805 North Creek Parkway, Bothell, WA, United States, 98011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
